Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00570_DB01072_nanopub.RAbuyBMs65H0ckhTyoyGs4dS73Hts4qb18L4QSrjnw1xQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00570_DB01072 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00570_DB01072 label "DDI between Vinblastine and Atazanavir - Atazanavir, a strong CYP3A4 inhibitor, may decrease the metabolism of Vinblastine. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Atazanavir is initiated, discontinued or dose changed. [drugbank_resource:DB00570_DB01072]" assertion.
- drugbank_resource:DB00570_DB01072 identifier "drugbank_resource:DB00570_DB01072" assertion.
- drugbank_resource:DB00570_DB01072 title "DDI between Vinblastine and Atazanavir - Atazanavir, a strong CYP3A4 inhibitor, may decrease the metabolism of Vinblastine. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Atazanavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00570 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB01072 assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB01072 assertion.